Compared with net loss of $130.6 million in Q1 2025 Tandem Diabetes Care plans to file a 510(k) submission with the Food and Drug Administration this quarter for its first tubeless insulin pump. The ...

The FDA cleared an automated insulin delivery system for use by pregnant women with type 1 diabetes, according to an industry ...

When Polly Varnado's 9-year-old daughter was diagnosed with Type 1 diabetes, it didn't take long for the family to hear about insulin pumps. In September 2012, the girl picked out a purple one — her ...

Insulet raised its annual revenue growth forecast on Wednesday after reporting better-than-expected quarterly results, driven by ​strong demand for its tubeless insulin ‌pumps that eliminate the need ...

Allowing patients to keep using their personal diabetes technology during hospitalization improves glycemic control and reduces length of stay.

(CNN) -- Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on ...

Insulin pump use during hospitalization may improve glycemic outcomes and reduce length of stay for people with diabetes, ...

Including continuous glucose monitors (CGMs) and insulin pumps in the next round of Medicare’s competitive bidding program overlooks how they are used and will not result in savings ...

Insulin pumps are a medical device used by people with diabetes to automatically deliver a measured dose of insulin into their bloodstream. Traditionally they have involved a canula and separate ...

Insulin pumps can help people with diabetes manage their blood sugar levels. The small, wearable electronic device gives predetermined rates of insulin to your body. You may want to use an insulin ...

"MiniMed 508" Medtronic insulin pumps have cybersecurity problems that can't be updated or patched, and the company is recalling them as a result, the Food and Drug Administration said Thursday. It's ...

Insulet stock jumped early Wednesday on a solid first-quarter report and a sales guidance boost for the year.